Happy 20th Anniversary to LANA!

Jane M Armer, RN PhD FAAN CLT


Date of original LANA certification: 07/01/2016
LANA Certificate Expires: 12/31/2022

University of Missouri
DC 116.05 Suite 408 115 Bus. Loop 70 West
Columbia, MO 65211
573-882-0287
Biography
Dr. Jane Armer, PhD, RN, FAAN, Professor, Sinclair School of Nursing, University of Missouri,
and Director, Nursing Research, Ellis Fischel Cancer Center (EFCC), has conducted research
in the area of lymphedema prevalence, signs and symptoms, symptom management,
anthropometric measurement, and quality of life among breast cancer survivors; and fatigue
among persons with lymphedema. She is the Principal Investigator on a multi-year R01 study
funded by National Institute for Nursing Research (National Institutes of Health) which follows
breast cancer survivors prospectively from pre-surgery through 84 months post-op to assess
limb volume changes over time. Dr. Armer has published 60 research articles in the refereed
literature, 30 of which are focused on lymphedema, and has lectured internationally on the topic
of lymphedema.

She received training as a lymphedema therapist through the Lerner Institute on Lymphatic
Studies in 1998. She has appointments to the following organizations: the National Lymphedema
Network Medical Advisory Committee (NLN-MAC) where she served as founding chair of the
NLN-MAC Research subcommittee and is a member of the editorial and scientific program-
planning committees; the board of directors for the Lymphology Association of North America
(LANA); the Oncology Nursing Society (ONS) Research Advisory Committee; and three NCI-
funded national clinical trials cooperative groups, CALG-B and ACOSOG (now the Alliance),
and GOG, where she is a co-investigator in the development of research protocols focused on
lymphedema risk-reduction in cancer survivors and where she formerly served as vice-chair of
the CALG-B symptom intervention subcommittee. She is director of the American Lymphedema
Framework Project and serves on the international advisory board of the International
Lymphoedema Framework.